Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer

BACKGROUND: Mutational analysis of the KRAS gene has recently been established as a complementary in vitro diagnostic tool for the identification of patients with colorectal cancer who will not benefit from anti-epidermal growth factor receptor (EGFR) therapies. Assessment of the mutation status of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sánchez-Muñoz, Alfonso, Gallego, Elena, de Luque, Vanessa, Pérez-Rivas, Luís G, Vicioso, Luís, Ribelles, Nuria, Lozano, José, Alba, Emilio
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2868051/
https://ncbi.nlm.nih.gov/pubmed/20385028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-136
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars